The goal of hematopoietic stem cell transplant (HSCT) is to reset the immune system and stop inflammation
that contributes to MS. A specific type of HSCT, “autologous,” or aHSCT, uses stem cells from your own body instead of using donor stem cells.
AHSCT is considered the safest form of HSCT in MS. There is growing evidence that aHSCT may be highly effective for people with relapsing MS who meet very specific characteristics. Learn more about the use of aHSCT in treating MS
, including what’s involved in the procedure and cost.
Worldwide, MS researchers are focusing on who may benefit from aHSCT and how to reduce its risks.